Private Portfolio Partners LLC Invests $231,000 in Corteva (NYSE:CTVA)
Private Portfolio Partners LLC purchased a new position in shares of Corteva (NYSE:CTVA) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 7,797 shares of the company’s stock, valued at approximately $231,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Litman Gregory Asset Management LLC acquired a new stake in shares of Corteva during the second quarter worth about $26,000. Executive Wealth Management LLC acquired a new stake in shares of Corteva during the second quarter worth about $27,000. Roble Belko & Company Inc acquired a new stake in shares of Corteva during the second quarter worth about $29,000. Compagnie Lombard Odier SCmA acquired a new stake in Corteva in the 2nd quarter valued at approximately $29,000. Finally, SRS Capital Advisors Inc. acquired a new stake in Corteva in the 2nd quarter valued at approximately $30,000. 72.15% of the stock is currently owned by institutional investors.
Shares of NYSE:CTVA traded up $0.06 during trading on Thursday, hitting $29.21. 2,036,907 shares of the company were exchanged, compared to its average volume of 3,896,006. Corteva has a fifty-two week low of $24.35 and a fifty-two week high of $32.78. The firm has a fifty day simple moving average of $29.74.
The business also recently declared a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Wednesday, July 31st were given a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a dividend yield of 1.78%. The ex-dividend date was Tuesday, July 30th.
In other Corteva news, Director Klaus A. Engel bought 18,393 shares of Corteva stock in a transaction dated Friday, August 30th. The stock was bought at an average cost of $30.00 per share, for a total transaction of $551,790.00. Following the purchase, the director now owns 25,253 shares of the company’s stock, valued at approximately $757,590. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
A number of equities research analysts recently issued reports on CTVA shares. SunTrust Banks started coverage on Corteva in a research report on Monday, June 3rd. They issued a “hold” rating and a $29.00 target price on the stock. Macquarie started coverage on Corteva in a research report on Tuesday, June 4th. They issued an “outperform” rating on the stock. Jefferies Financial Group started coverage on Corteva in a research report on Wednesday, May 29th. They issued a “buy” rating on the stock. Barclays reissued a “hold” rating and issued a $35.00 target price on shares of Corteva in a research report on Sunday, August 4th. Finally, Nomura started coverage on Corteva in a research report on Monday, June 10th. They issued a “neutral” rating and a $28.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $32.25.
Corteva, Inc provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health.
Featured Article: Asset Allocation and Your Retirement
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.